Tredje AP fonden Reduces Position in Molina Healthcare, Inc. (NYSE:MOH)

Tredje AP fonden lessened its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 50.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,544 shares of the company's stock after selling 4,543 shares during the quarter. Tredje AP fonden's holdings in Molina Healthcare were worth $1,323,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of MOH. Janney Montgomery Scott LLC raised its holdings in shares of Molina Healthcare by 3.0% during the 3rd quarter. Janney Montgomery Scott LLC now owns 2,509 shares of the company's stock valued at $865,000 after buying an additional 72 shares in the last quarter. GSA Capital Partners LLP raised its holdings in shares of Molina Healthcare by 57.4% during the 3rd quarter. GSA Capital Partners LLP now owns 3,620 shares of the company's stock valued at $1,247,000 after buying an additional 1,320 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Molina Healthcare by 1.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 146,335 shares of the company's stock valued at $50,421,000 after buying an additional 1,778 shares in the last quarter. Victory Capital Management Inc. raised its holdings in shares of Molina Healthcare by 6.5% during the 3rd quarter. Victory Capital Management Inc. now owns 94,834 shares of the company's stock valued at $32,676,000 after buying an additional 5,751 shares in the last quarter. Finally, Metis Global Partners LLC raised its holdings in shares of Molina Healthcare by 1.4% during the 3rd quarter. Metis Global Partners LLC now owns 2,785 shares of the company's stock valued at $960,000 after buying an additional 39 shares in the last quarter. Institutional investors own 98.50% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on MOH shares. Truist Financial decreased their price objective on Molina Healthcare from $370.00 to $340.00 and set a "buy" rating on the stock in a report on Wednesday, February 19th. UBS Group lowered their price objective on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research report on Friday, February 7th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $350.00 price objective (down previously from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. StockNews.com downgraded Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Monday, March 10th. Finally, Stephens reiterated an "equal weight" rating and issued a $345.00 price objective on shares of Molina Healthcare in a research report on Thursday, February 6th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $355.69.

Insider Buying and Selling

In related news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now directly owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.10% of the stock is owned by insiders.

Molina Healthcare Trading Down 0.8 %

Shares of Molina Healthcare stock traded down $2.41 during midday trading on Wednesday, reaching $314.66. 545,423 shares of the company's stock traded hands, compared to its average volume of 606,953. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The company has a market cap of $17.46 billion, a PE ratio of 15.40, a price-to-earnings-growth ratio of 1.06 and a beta of 0.56. The stock has a 50 day moving average of $298.86 and a 200-day moving average of $309.90. Molina Healthcare, Inc. has a 12 month low of $262.32 and a 12 month high of $423.92.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, equities analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.